Related Experiment Video
Updated: Mar 2, 2026

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
Published on: March 25, 2020
Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R
Harilaos Filippakis1, Nicola Alesi1, Barbara Ogorek1
1Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Abstract:
Tuberous sclerosis complex (TSC) is a multisystem disease associated with hyperactive mTORC1. The impact of TSC1/2 deficiency on lysosome-mediated processes is not fully understood. We report here that inhibition of lysosomal function using chloroquine (CQ) upregulates cholesterol homeostasis genes in TSC2-deficient cells. This TSC2-dependent transcriptional signature is associated with increased accumulation and intracellular levels of both total cholesterol and cholesterol esters. Unexpectedly, engaging this CQ-induced cholesterol uptake pathway together with inhibition of de novo cholesterol synthesis allows survival of TSC2-deficient, but not TSC2-expressing cells. The underlying mechanism of TSC2-deficient cell survival is dependent on exogenous cholesterol uptake via LDL-R, and endosomal trafficking mediated by Vps34. Simultaneous inhibition of lysosomal and endosomal trafficking inhibits uptake of esterified cholesterol and cell growth in TSC2-deficient, but not TSC2-expressing cells, highlighting the TSC-dependent lysosome-mediated regulation of cholesterol homeostasis and pointing toward the translational potential of these pathways for the therapy of TSC.
Insights
Tuberous sclerosis complex (TSC) cells survive chloroquine treatment by upregulating cholesterol uptake. This pathway, dependent on TSC2, offers potential therapeutic targets for TSC.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Tuberous sclerosis complex (TSC) is a genetic disorder characterized by hyperactive mTORC1 signaling.
- The role of TSC1/2 deficiency in lysosome-mediated cellular processes, particularly cholesterol homeostasis, remains unclear.
Purpose of the Study:
- To investigate the impact of lysosomal inhibition on cholesterol metabolism in TSC2-deficient cells.
- To elucidate the mechanisms underlying cell survival in TSC2-deficient cells under specific treatment conditions.
Main Methods:
- Utilized chloroquine (CQ) to inhibit lysosomal function in TSC2-deficient and TSC2-expressing cells.
- Analyzed gene expression related to cholesterol homeostasis.
- Quantified intracellular cholesterol and cholesterol ester levels.
- Investigated the role of LDL-R and Vps34 in endosomal trafficking and cholesterol uptake.
Main Results:
- Chloroquine treatment upregulated cholesterol homeostasis genes in TSC2-deficient cells, leading to increased cholesterol and ester accumulation.
- Combined inhibition of lysosomal function and de novo cholesterol synthesis promoted survival specifically in TSC2-deficient cells.
- Cell survival was dependent on LDL-R-mediated exogenous cholesterol uptake and Vps34-dependent endosomal trafficking.
- Inhibition of both lysosomal and endosomal trafficking impaired cholesterol uptake and cell growth in TSC2-deficient cells.
Conclusions:
- TSC2 deficiency alters lysosome-mediated regulation of cholesterol homeostasis.
- Targeting cholesterol uptake and trafficking pathways presents a potential therapeutic strategy for Tuberous Sclerosis Complex.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Regulation of Nuclear Protein Sorting
Lysosomal Hydrolases
The Early Endosome: Endocytosis of Transferrin
Receptor-mediated Endocytosis
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

